Tim R. de Back
Tim R. de Back publishes mostly in Oncology, Surgery and Pathology and Forensic Medicine, on topics such as Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer and Gastrointestinal Tumor Research and Treatment.
- World rank
- #1,687,048 of 7,710,434 ranked researchers
- Rank in Netherlands
- #37,457 of 107,149
- Works
- 21
- Citations
- 679
- Citations per work
- 32.3
What does Tim R. de Back research?
Tim R. de Back's work is mostly in Medicine (67%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1466.6%
- Medicine1466.6%
- Everything else733.4%
- 1Oncology22% of their works
- 2Surgery14% of their works
- 3Pathology and Forensic Medicine10% of their works
- 4Gastroenterology8% of their works
- 5Pulmonary and Respiratory Medicine8% of their works
- 6Genetics6% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Gastrointestinal Tumor Research and Treatment
- Gastric Cancer Management and Outcomes
- Hemoglobinopathies and Related Disorders
- Iron Metabolism and Disorders
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
Which keywords describe Tim R. de Back's research?
The keywords of their largest research topics: Chemotherapy, Molecular Characterization, Adjuvant Chemotherapy, Cetuximab, Clinical Practice Guidelines, KRAS Mutations, Hereditary Syndromes and Microsatellite Instability.
- Surgical Complications
- Rectal Cancer
- Pancreatic Cancer
- Hepcidin
- Neoadjuvant Therapy
- Gastric Cancer
- Microsatellite Instability
- KRAS Mutations
- Cetuximab
- Molecular Characterization
- Chemotherapy
- Adjuvant Chemotherapy
- Clinical Practice Guidelines
- Hereditary Syndromes
- Endoscopic Resection
- Imatinib Mesylate
- Sunitinib
- Iron Regulation
- Preoperative Chemoradiotherapy
- Sickle-cell Disease
- Thalassemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Chemotherapy123 topics
- Molecular Characterization92 topics
- Adjuvant Chemotherapy72 topics
- Cetuximab61 topic
- Clinical Practice Guidelines62 topics
- KRAS Mutations61 topic
- Hereditary Syndromes51 topic
- Microsatellite Instability51 topic
- Endoscopic Resection41 topic
- Gastric Cancer41 topic
- Imatinib Mesylate41 topic
- Neoadjuvant Therapy42 topics
- Sunitinib41 topic
- Hepcidin21 topic
- Iron Regulation21 topic
- Pancreatic Cancer21 topic
- Preoperative Chemoradiotherapy21 topic
- Rectal Cancer21 topic
- Sickle-cell Disease21 topic
- Surgical Complications21 topic
- Thalassemia21 topic
Where does Tim R. de Back work?
Tim R. de Back's main affiliation in the publication record is Oncode Institute, Netherlands.
How many publications and citations does Tim R. de Back have?
OpenAlex counts 21 works and 679 citations for Tim R. de Back, an h-index of 10, ranking #1,687,048 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tim R. de Back. Posts are plain text and can be reported.